These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8530508)
1. Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells. Graham JD; Roman SD; McGowan E; Sutherland RL; Clarke CL J Biol Chem; 1995 Dec; 270(51):30693-700. PubMed ID: 8530508 [TBL] [Abstract][Full Text] [Related]
2. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830 [TBL] [Abstract][Full Text] [Related]
3. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Alexander IE; Clarke CL; Shine J; Sutherland RL Mol Endocrinol; 1989 Sep; 3(9):1377-86. PubMed ID: 2608065 [TBL] [Abstract][Full Text] [Related]
4. Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D. Clarke CL; Graham J; Roman SD; Sutherland RL J Biol Chem; 1991 Oct; 266(28):18969-75. PubMed ID: 1918012 [TBL] [Abstract][Full Text] [Related]
5. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. Wu J; Richer J; Horwitz KB; Hyder SM Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368 [TBL] [Abstract][Full Text] [Related]
6. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Cho H; Aronica SM; Katzenellenbogen BS Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831 [TBL] [Abstract][Full Text] [Related]
7. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737 [TBL] [Abstract][Full Text] [Related]
8. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825 [TBL] [Abstract][Full Text] [Related]
9. A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells. Zheng ZY; Bay BH; Aw SE; Lin VC J Biol Chem; 2005 Apr; 280(17):17480-7. PubMed ID: 15728178 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Lee YJ; Gorski J Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15180-4. PubMed ID: 8986784 [TBL] [Abstract][Full Text] [Related]
11. The effect of progestins on prolactin receptor gene transcription in human breast cancer cells. Ormandy CJ; Graham J; Kelly PA; Clarke CL; Sutherland RL DNA Cell Biol; 1992 Dec; 11(10):721-6. PubMed ID: 1457040 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells. Bamberger AM; Thuneke I; Schulte HM Breast Cancer Res Treat; 1998 Jan; 47(2):153-61. PubMed ID: 9497103 [TBL] [Abstract][Full Text] [Related]
13. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters. Kraus WL; Montano MM; Katzenellenbogen BS Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766 [TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
15. Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms. Kuil CW; Brouwer A; van der Saag PT; van der Burg B J Biol Chem; 1998 Apr; 273(15):8829-34. PubMed ID: 9535862 [TBL] [Abstract][Full Text] [Related]
16. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang Y; Wu J; Stancel GM; Hyder SM J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260 [TBL] [Abstract][Full Text] [Related]
18. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. McFall T; Patki M; Rosati R; Ratnam M Oncotarget; 2015 Oct; 6(32):33146-64. PubMed ID: 26356672 [TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. Clarke CL; Roman SD; Graham J; Koga M; Sutherland RL J Biol Chem; 1990 Jul; 265(21):12694-700. PubMed ID: 2373707 [TBL] [Abstract][Full Text] [Related]
20. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]